Bristol Myers Squibb Canada

Bristol Myers Squibb Canada is the national affiliate of the global biopharmaceutical leader Bristol Myers Squibb, with its headquarters located in Montreal, Quebec. The company is dedicated to the discovery, development, and delivery of innovative medicines designed to help patients overcome serious diseases. Its core therapeutic focus areas include oncology, hematology, cardiovascular diseases, and immunology. BMS Canada is a significant contributor to the Canadian life sciences ecosystem, managing a robust portfolio of clinical trials and providing access to transformative therapies such as Opdivo and Eliquis. The organization maintains a strong commitment to scientific innovation and collaborates closely with healthcare providers and research institutions across the country. By focusing on high-unmet-need areas, BMS Canada strives to improve patient outcomes and enhance the quality of care within the Canadian healthcare system.